During the past decade, Oakland Colon Rectal Associates conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 18 clinical trials were completed, i.e. on average, 48.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 18 clinical trials were completed. i.e. 257.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oakland Colon Rectal Associates" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "NRG Oncology" with 5 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oakland Colon Rectal Associates" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Oakland Colon Rectal Associates" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Stage IIIA Breast Cancer" (5 trials), "Stage II Breast Cancer" (4 trials) and "Chronic Lymphocytic Leukemia" (3 trials). Many other conditions were trialed in "Oakland Colon Rectal Associates" in a lesser frequency.

Most popular intervention types in "Oakland Colon Rectal Associates" are "Other" (38 trials), "Drug" (36 trials), "Biological" (14 trials), "Procedure" (13 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (16 trials), "Questionnaire Administration" (8 trials), "Computed Tomography" (7 trials) and "Biospecimen Collection" (6 trials). Other intervention names were less common.

The vast majority of trials in "Oakland Colon Rectal Associates" are 42 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Oakland Colon Rectal Associates". undefined are not yet recruiting, 8 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Oakland Colon Rectal Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Oakland Colon Rectal Associates, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".